CIK 0000818686 · Large accelerated filer
TEVA PHARMACEUTICAL INDUSTRIES LTD
Sign in to watch- Ticker
- TEVA
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Israel
- Entity type
- operating
- Phone
- 972 (3) 914-8213
- Business address
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED, 124 DVORA HANEVI'A ST., TEL AVIV, Israel
- Former names
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $33,242,786
- in 10 filings, $10.6M under 10b5-1 plans
Net −$33,242,786. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-02-15 | Francis Richard D President and CEO | Option exercise 10b5-1 | +161,655 | 161,655 | ||
| 2024-02-15 | Francis Richard D President and CEO | Sale 10b5-1 | −74,530 | $13.15 | $980K | 87,125 |
| 2024-02-15 | Francis Richard D President and CEO | Option exercise · Restricted Share Units 10b5-1 | −161,655 | 323,311 | ||
| 2024-02-13 | Kalif Eliyahu Sharon EVP, Chief Financial Officer | Option exercise | +6,630 | 105,792 | ||
| 2024-02-13 | Kalif Eliyahu Sharon EVP, Chief Financial Officer | Option exercise · Restricted Share Units | −6,630 | 0 | ||
| 2024-02-01 | Weiss Amir Chief Accounting Officer | Sale | −31,766 | $12.37 | $393K | 10,676 |
| 2024-01-30 | Daniell Richard Exec. VP, European Commercial | Grant or award · Restricted Share Units | +55,226 | 55,226 | ||
| 2024-01-30 | Kalif Eliyahu Sharon EVP, Chief Financial Officer | Grant or award · Restricted Share Units | +52,320 | 52,320 | ||
| 2024-01-30 | Drape Eric Executive VP Global Operations | Grant or award · Restricted Share Units | +55,226 | 55,226 | ||
| 2024-01-30 | Sabag Mark EVP, International Markets | Grant or award · Restricted Share Units | +58,133 | 58,133 | ||
| 2023-11-20 | Fox Christine EVP, Head of U.S. Commercial | Grant or award · Restricted Share Units | +253,968 | 253,968 | ||
| 2023-11-15 | Conway Vikki L See "Remarks" | Grant or award · Restricted Share Units | +33,482 | 33,482 | ||
| 2023-11-15 | Bergwerk Dov Acting Chief Legal Officer | Grant or award · Restricted Share Units | +33,482 | 33,482 | ||
| 2023-09-02 | Shalev Varda Director | Grant or award · Restricted Share Units | +12,872 | 12,872 | ||
| 2023-08-09 | Grant Angus EVP, Business Development | Grant or award · Restricted Share Units | +51,652 | 51,652 | ||
| 2023-08-07 | Kalif Eliyahu Sharon EVP, Chief Financial Officer | Sale | −35,125 | $9.73 | $342K | 99,162 |
| 2023-08-04 | Weiss Amir Chief Accounting Officer | Sale | −1,981.41 | $9.92 | $20K | 42,442 |
| 2023-08-04 | Zaks Tal Zvi Director | Option exercise | +15,810 | 28,032 | ||
| 2023-08-04 | Zaks Tal Zvi Director | Option exercise · Restricted Share Units | −15,810 | 0 | ||
| 2023-08-04 | Vergis Janet S. Director | Option exercise | +15,810 | 42,957 |
Page 26 of 76 · 1,517 trades